文献速递心血管胸部MR

心脏磁共振晚期钆增强对心脏结节病预后的价值

Prognostic Value of Late Gadolinium Enhancement Detected on Cardiac Magnetic Resonance in Cardiac Sarcoidosis.
PubMed 文献 · JACC Cardiovasc Imaging · 2023-01-11

该系统评价与Meta分析纳入13项研究共1318例已知或疑似心脏结节病患者,评估心脏磁共振晚期钆增强(LGE)的预后价值。中位随访3.1年,LGE阳性者室性心律失常(OR 20.3)、全因死亡(OR 3.45)及复合终点(OR 9.2)风险均显著升高;双心室LGE与室性心律失常风险进一步升高相关(OR 43.6)。

要点

  • 心脏结节病患者CMR检出LGE者室性心律失常风险显著升高(OR 20.3,95%CI 8.1-51.0)。
  • LGE阳性者全因死亡风险升高(OR 3.45,95%CI 1.6-7.3),复合终点风险亦升高(OR 9.2)。
  • 双心室LGE者室性心律失常风险更高(OR 43.6,95%CI 16.2-117.2)。

核心结论

  • 已知或疑似心脏结节病患者中,CMR检出LGE与室性心律失常和全因死亡风险显著升高相关;双心室LGE可能提供额外的致心律失常风险预后信息。

研究设计与样本

  • 系统评价与Meta分析,检索Embase和MEDLINE自建库至2022年3月,纳入13项研究共1318例已知或疑似心脏结节病转诊行CMR-LGE检查的患者,平均年龄52.0岁,LGE患病率13%至70%,随访3.1年。

关键影像表现/征象

  • CMR检出LGE者与无LGE者相比,室性心律失常风险升高(OR 20.3,95%CI 8.1-51.0)。
  • LGE阳性者全因死亡风险升高(OR 3.45,95%CI 1.6-7.3)。
  • LGE阳性者死亡或室性心律失常复合终点风险升高(OR 9.2,95%CI 5.1-16.7)。
  • 右心室LGE总是伴随左心室LGE出现。
  • 双心室LGE者室性心律失常风险显著升高(OR 43.6,95%CI 16.2-117.2)。

临床应用与阅片要点

  • 对于已知或疑似心脏结节病患者,CMR检出LGE提示室性心律失常和全因死亡风险升高,双心室LGE可能进一步提示致心律失常风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Sarcoidosis is a complex multisystem inflammatory disorder, with approximately 5% of patients having overt cardiac involvement. Patients with cardiac sarcoidosis are at an increased risk of both ventricular arrhythmias and sudden cardiac death. Previous studies have shown that the presence of late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) is associated with an increased risk of mortality and ventricular arrhythmias and may be useful in predicting prognosis.

OBJECTIVES: This systematic review and meta-analysis assessed the value of LGE on CMR imaging in predicting prognosis for patients with known or suspected cardiac sarcoidosis.

METHODS: The authors searched the Embase and MEDLINE databases from inception to March 2022 for studies reporting individuals with known or suspected cardiac sarcoidosis referred for CMR with LGE. Outcomes were defined as all-cause mortality, ventricular arrhythmia, or a composite outcome of either death or ventricular arrhythmias. The primary analysis evaluated these outcomes according to the presence of LGE. A secondary analysis evaluated outcomes specifically according to the presence of biventricular LGE.

RESULTS: Thirteen studies were included (1,318 participants) in the analysis, with an average participant age of 52.0 years and LGE prevalence of 13% to 70% over a follow-up of 3.1 years. Patients with LGE on CMR vs those without had higher odds of ventricular arrhythmias (odds ratio [OR]: 20.3; 95% CI: 8.1-51.0), all-cause mortality (OR: 3.45; 95% CI: 1.6-7.3), and the composite of both (OR: 9.2; 95% CI: 5.1-16.7). Right ventricular LGE is invariably accompanied by left ventricular LGE. Biventricular LGE is also associated with markedly increased odds of ventricular arrhythmias (OR: 43.6; 95% CI: 16.2-117.2).

CONCLUSIONS: Patients with known or suspected cardiac sarcoidosis with LGE on CMR have significantly increased odds of both ventricular arrhythmias and all-cause mortality. The presence of biventricular LGE may confer additional prognostic information regarding arrhythmogenic risk.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Stevenson A, Bray JJH, Tregidgo L, et al. Prognostic Value of Late Gadolinium Enhancement Detected on Cardiac Magnetic Resonance in Cardiac Sarcoidosis. JACC Cardiovasc Imaging. 2023. PMID: 36752432. doi:10.1016/j.jcmg.2022.10.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。